Oxford Nanopore Technologies (LON:ONT) Insider Acquires £148.35 in Stock

Key Points

• Insider buying: Oxford Nanopore director Nick Keher purchased 69 shares at GBX 215 each, worth £148.35. He has made several purchases since August, including 15,325 shares valued at £24,826.50.
• Stock performance and finances: ONT shares fell 1.1% to GBX 208.60, while the company reported negative earnings of GBX 4.90 per share, a negative net margin of 54.66%, and negative return on equity of 35.45%.
• Analyst outlook: Analysts have assigned the stock a consensus “Moderate Buy” rating, with five Buy ratings and one Hold rating, and an average price target of GBX 198.60.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Nick Keher bought 69 shares of the firm's stock in a transaction that occurred on Wednesday, October 14th. The shares were purchased at an average cost of GBX 215 per share, with a total value of £148.35.

Nick Keher also recently made the following trade(s):

• On Monday, September 14th, Nick Keher bought 96 shares of Oxford Nanopore Technologies stock. The stock was purchased at an average price of GBX 157 per share, with a total value of £150.72.
• On Friday, September 4th, Nick Keher purchased 15,325 shares of Oxford Nanopore Technologies stock. The stock was purchased at an average cost of GBX 162 per share, for a total transaction of £24,826.50.
• On Wednesday, August 12th, Nick Keher purchased 115 shares of Oxford Nanopore Technologies stock. The stock was purchased at an average cost of GBX 131 per share, for a total transaction of £150.65.

Oxford Nanopore Technologies Stock Down 1.1%

Shares of ONT stock traded down GBX 2.40 during trading hours on Wednesday, reaching GBX 208.60. 1,681,754 shares of the company's stock were exchanged, compared to its average volume of 9,552,693. The stock's 50 day moving average is GBX 169.50 and its 200-day moving average is GBX 136.77. The company has a market cap of £2.04 billion, a price-to-earnings ratio of -16.69 and a beta of 0.87. The company has a current ratio of 3.52, a quick ratio of 6.01 and a debt-to-equity ratio of 9.86. Oxford Nanopore Technologies plc has a fifty-two week low of GBX 95.61 and a fifty-two week high of GBX 238.80.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last announced its earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative net margin of 54.66% and a negative return on equity of 35.45%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ONT shares. Citigroup downgraded Oxford Nanopore Technologies to a "buy" rating in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 195 price objective on shares of Oxford Nanopore Technologies in a report on Thursday, August 20th. Berenberg Bank cut their price objective on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating on the stock in a research note on Wednesday, August 19th. Peel Hunt reissued a "hold" rating and set a GBX 153 target price on shares of Oxford Nanopore Technologies in a report on Monday, July 13th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a research report on Thursday, August 27th. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of GBX 198.60.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.